&Partners’s Incyte INCY Stock Holding History

&Partners’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$392K	Buy	3,457 +728	+27%	+$72.2K	﹤0.01%	1973
2026 Q1	$257K	Buy	+2,729	New	+$272K	﹤0.01%	2087

Other funds holding INCY

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

&Partners's INCY Position: Q2 2026 in Review

&Partners increased its Incyte (INCY) stake by 27% in Q2 2026, buying an estimated $72.2K and bringing the position to 3,457 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #1973.

&Partners first reported a position in INCY in Q1 2026 and has held it in 2 quarters since. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

&Partners held 3,457 shares of Incyte worth $392K as of Q2 2026.
&Partners bought 728 Incyte shares in Q2 2026, an estimated $72.2K.
Incyte made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1973 holding.
&Partners first reported a position in Incyte in Q1 2026 and has held it in 2 quarters since.
859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.